Ophthalmology

The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

Mina Massaro-Giordano, MD
Patients With Dry Eye Have More Treatment Options Than Ever Before: A Q&A With Mina Massaro-Giordano, MD

July 18th 2025

The symptoms of dry eye are multifactorial, says Mina Massaro-Giordano, MD, making identifying and treating dry eye important for quality of life.

Man using eye drops | Image credit: 9nong - stock.adobe.com
Dry Eye Awareness Month Highlights Condition Affecting Millions

July 8th 2025

Man applying eye drops | Image credit: StockImageFactory
Education Surrounding Dry Eye a Persistent Barrier in Treatment

July 8th 2025

Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease
Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease

July 7th 2025

Dry eye | Image credit: Kryuchka Yaroslav - stock.adobe.com
Tear Film Instability More Severe in Patients With Dry Eye, Diabetes

July 2nd 2025

Continuing Medical Education
View All
July 20th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 20th 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
July 20th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
July 20th 2025

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry
July 20th 2025

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credits / Ophthalmology/Optometry
July 20th 2025

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry
July 20th 2025

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

1.5 Credit / Ophthalmology/Optometry

More News

Child with eye patch | Image credit: Maxim Kukurund - stock.adobe.com
October 3rd 2024

Age at Diagnosis Associated With Disparities in Amblyopia Resolution

Julia Bonavitacola
Interventions to diagnosis amblyopia earlier could help in addressing inequities in the resolution of amblyopia.
Eye | Image credit: Liudmila Dutko - stock.adobe.com
September 28th 2024

Depressive Disorder at Higher Risk of Development in Patients With Retinitis Pigmentosa

Julia Bonavitacola
Emotional and social support for patients with retinitis pigmentosa could reduce the incidence of depressive disorder in this demographic.
Glasses with letters | Image credit: Miroslav110 - stock.adobe.com
September 16th 2024

MYL-1701P Efficient, Safe Compared With Aflibercept in Diabetic Macular Edema

Julia Bonavitacola
MYL-1701P displayed similar efficacy, safety, and immunogenicity when compared with reference aflibercept to treat diabetic macular edema.
Patient undergoing OCT imaging | Image credit: Richman Photo - stock.adobe.com
September 11th 2024

AI Can Enhance OCT Analysis for Retinal Disease Monitoring

Julia Bonavitacola
An AI segmentation system was able to identify changes in retinal segmented features based on optical coherence tomography (OCT) images.
Dementia | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com
September 5th 2024

Vision Health May Be a Modifiable Risk Factor for Dementia, Study Finds

Julia Bonavitacola
Treating and preventing correctable vision impairments could prevent up to 19% of dementia prevalence, according to a new study.
Eye exam | Image credit: Elena Verba - stock.adobe.com
August 26th 2024

Eye Disease Detection Programs in Underserved Areas Could Improve Treatment

Julia Bonavitacola
Primary care clinics in underserved areas including eye disease detection programs could reduce vision loss in the US.
Quint Petris
August 6th 2024

Asking the Right Questions Can Help Identify Dry Eye Disease in Patients

Julia Bonavitacola
Jessilin Quint of Smart Eye Care and Rebecca Petris of Dry Eye Foundation talk about how health care and eye care professionals can educate and identify patients with dry eye.
Prior authorization | Image credit: Maksim Shchur - stock.adobe.com
Published: August 1st 2024 | Updated: August 1st 2024

Prior Authorization Process Not Effective for Retina Specialists

Julia Bonavitacola
A new study has found that prior authorizations for anti–vascular endothelial growth factor treatment led to a delay in patient care for most patients.
Mina Massaro-Giordano, MD
July 30th 2024

Primary Care Doctors, Optometrists Can Raise Awareness About Dry Eye

Julia Bonavitacola
Mina Massaro-Giordano, MD, discusses how raising awareness about dry eye can help patients avoid worsening the condition.
Quint and Petris
July 19th 2024

Dry Eye Symptoms Affect Patients of All Ages

Julia Bonavitacola
Jessilin Quint, OD, MBA, FAAO, and Rebecca Petris discussed the different presentations of dry eye and how patients can address their symptoms with their doctors.
Mina Massaro-Giordano, MD
July 15th 2024

Dry Eye Affects Multiple Parts of Eye, Eyelid in Patients With Condition

Julia Bonavitacola
Mina Massaro-Giordano, MD, discussed the ways that dry eye can affect patients with the condition, as well as what symptoms can fly under the radar.
Quint Petris
July 11th 2024

Experts Discuss Survey Results Revealing Biggest Challenges in Patients Living With Dry Eye

Julia Bonavitacola
Jessilin Quint, OD, MBA, FAAO, from Smart Eye Care, and Rebecca Petris, co-founder of the Dry Eye Foundation, spoke about their biggest takeaways from a recent dry eye survey conducted by The Harris Poll on behalf of Bausch + Lomb.
FDA Approved
July 8th 2024

FDA Approves Faricimab PFS for Leading Causes of Vision Loss

Julia Bonavitacola
Patients with age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion can use faricimab-svoa as a prefilled syringe (PFS).
Applying eye drops | Image credit: dragonstock - stock.adobe.com
July 8th 2024

Survey Reveals Important Factors in Patients With Dry Eye

Julia Bonavitacola
Adult patients with dry eye revealed their different challenges and experiences when living with the disease.
Dry eye | Image credit: lenblr - stock.adobe.com
July 4th 2024

Device Can Distinguish Between Patients With and Without Dry Eye Disease

Julia Bonavitacola
Patients with dry eye disease can be distinguished from patients with healthy eyes using a new artificial intelligence tool.
Endophthalmitis | Image credit: tutul_1410 - stock.adobe.com
June 24th 2024

Rate of Postoperative Endophthalmitis Similar Between 2 Modes of Treatment

Julia Bonavitacola
Incidence of postoperative endophthalmitis was low when patients were treated with either 1% povidone iodine disinfection with intracameral antibiotics or 5% povidone iodine with antibiotics.
Eye | Image credit: rangizzz - stock.adobe.com
June 19th 2024

Guidelines for Suprachoroidal Space Injection Technique Defined by Panel of Experts

Julia Bonavitacola
A panel of ophthalmologists defined points of consensus for suprachoroidal space injections based on current published evidence.
Man affected by eye pain | Image credit: Prostock-studio - stock.adobe.com
June 12th 2024

Eye Pain Visits to ED, Outpatient Setting Number 5 Million Annually

Julia Bonavitacola
Expanding ways to treat eye pain could reduce the burden on the emergency department (ED) and other areas of the health care system.
Woman rubbing eyes | Image credit: Yakobchuk Olena - stock.adobe.com
June 5th 2024

Dry Eye Associated With Living Near Industrial Zones, Exposure to Sulfur Dioxide

Julia Bonavitacola
Associations between ambient air pollutants and dry eye could have been mitigated during the pandemic.
Blue eye | Image credit: Vladimir Voronin - stock.adobe.com
May 23rd 2024

Double-Dose Aflibercept Relieved Treatment Burden, Displayed Anatomic Gains Compared With Regular Dose

Julia Bonavitacola
An aflibercept dose of 4 mg for macular degeneration was found to reduce both central macular thickness and pigmental epithelium detachment for a longer duration compared with the 2 mg dose.
Close of up of an older woman's eye | Image credit: Syda Productions - stock.adobe.com
May 20th 2024

First Aflibercept Biosimilars Approved in US

Skylar Jeremias
The FDA approved the first 2 biosimilars referencing aflibercept (Eylea). However, patent litigation has left it unclear when the biosimilars will come to market.
Woman's Eyes | Image credit: Africa Studio - stock.adobe.com
May 14th 2024

Visual Acuity, Retinal Sensitivity Improved With Intravitreal Ranibizumab Injection

Julia Bonavitacola
An intravitreal ranibizumab injection was able to improve retinal sensitivity and thickness along with improving visual acuity.
Older woman with Glaucoma | Image credit: Africa Studio - stock.adobe.com
May 8th 2024

Visual Field Progression, Doubling Risk of Event Progression Associated With Density Loss in Optic Nerve

Julia Bonavitacola
Density loss in the optic nerve head capillary could lead to a faster rate of visual field progression as well as an increased risk of developing event progression.
Artificial Intelligence | Image credit: Tierney - stock.adobe.com
May 1st 2024

Code-Free Models Effective at Classifying Retinal Pathologies

Julia Bonavitacola
Models that are code-free were able to perform as accurately as expert-designed bespoke models when classifying retinal pathologies.
Young child with eye patch | Image credit: Maxim Kukurund - stock.adobe.com
April 22nd 2024

Family, Child Functioning Not Negatively Associated With Occlusion Therapy

Julia Bonavitacola
Findings from a study with a limited sample size suggest that patching is both effective and does not impede development in children who patch for at least 120 minutes each day.
Woman with strabismus | Image credit: Volodymyr - stock.adobe.com
April 16th 2024

Strabismus Associated With Mental Health Conditions in Adults

Julia Bonavitacola
Poor mental health was worse in adults with strabismus compared with adults without strabismus.
Older woman with tablet | Image credit: auremar - stock.adobe.com
April 8th 2024

Older Adults With VI Less Likely to Have Access to Digital Technology

Julia Bonavitacola
Digital technology being less accessible to adult patients with vision impairment (VI) could be a detriment to telemedicine accessibility.
Human heart | Image credit: abhijith3747 - stock.adobe.com
April 4th 2024

Valvular Heart Disease Associated With AMD Subset

Julia Bonavitacola
The subretinal drusenoid deposit form of age-related macular degeneration (AMD) was found to be associated with valvular heart disease as well as cardiac index.
Close up of eye | Image credit: Liudmila Dutko - stock.adobe.com
March 26th 2024

Intraocular Inflammation, Retinal Vascular Occlusion Infrequent in Treatment With Brolucizumab

Julia Bonavitacola
A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis.
Older woman with Glaucoma | Image credit: Africa Studio - stock.adobe.com
March 20th 2024

Increased Risk of POAG Associated With Polygenic Risk Score

Julia Bonavitacola
Polygenic risk score was found to be associated with a higher risk of primary open angle glaucoma (POAG) in patients with ocular hypertension.
<12345678
...
19>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo